BeOne Medicines
ONC
#717
Rank
C$45.15 B
Marketcap
C$393.19
Share price
2.20%
Change (1 day)
4.65%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

BeOne Medicines (ONC) - Net assets

Net assets on the balance sheet as of December 2025 : C$6.05 Billion

According to BeOne Medicines's latest financial reports the company has C$6.05 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

BeOne Medicines - Net assets on balance sheet (from 2014 to 2025)

Net assets by year

Year Net assets Change
2025-12-31$C$5.97 B24.9%
2024-12-31$C$4.78 B1.92%
2023-12-31$C$4.69 B-21.12%
2022-12-31$C$5.94 B-23.9%
2021-12-31$C$7.81 B58.42%
2020-12-31$C$4.93 B286.1%
2019-12-31$C$1.27 B-46.51%
2018-12-31$C$2.38 B177.69%
2017-12-31$C$0.86 B81.39%
2016-12-31$C$0.47 B360.02%
2015-12-31$C$0.10 B244.76%
2014-12-31$C$29.9 M-172.54%
2013-12-31$-C$41.23 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
OPKO Health
OPK
C$1.76 B-70.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
C$8.35 M-99.86%๐Ÿ‡บ๐Ÿ‡ธ USA